Drug
Nordihydroguaiaretic Acid
Nordihydroguaiaretic Acid: highest development phase Phase 2, developed by Insmed. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Insmed
Trials
| Drug | Phase | Indication |
|---|---|---|
| Nordihydroguaiaretic Acid (NDGA) NCT00678015 | Phase 2 | Prostate Cancer |
Latest
No recent events.
Follow Nordihydroguaiaretic Acid on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.